Korean pharmaceutical companies announced the start of business in 2021 through opening ceremony and New Year’s speech.
Through the New Year’s address, pharmaceutical companies have agreed that they need’drastic innovation and challenges’ such as open innovation in the face of an unprecedented new coronavirus infection (Corona 19) crisis.
In addition, he also revealed his ambitions for one year to leap to a global-level company, such as strengthening new drug development capabilities.
Daewoong Pharmaceutical held an online New Year’s Opening Ceremony on the morning of the 4th and pledged to focus its company-wide capabilities to break through the unprecedented crisis caused by Corona 19.
Daewoong Pharmaceutical’s President Seung-ho Jeon said in his new year address, “In 2020, we achieved solid results through the continued growth of’Nabota’ and the expansion of each business, such as ETC and OTC, even in difficult business environments.” “Let’s achieve continuous innovation to achieve the’Global 2025 Vision’ and grow sales in the environment that has rapidly changed due to Corona 19 this year,” he said.
As Daewoong Pharmaceutical’s management policy in 2021, the former president presented ▲Customer Value Improvement ▲Global Innovative New Drug Development ▲K-Pharma Global Leadership ▲Talent Development Leading Challenges and Changes.
In addition, “We will reinforce our R&D capabilities, a growth engine, and leap forward as a Korean global company through continuous open innovation that can create new values” and “Continuously disseminating examples of changing the way of thinking, awakening challenges and changes, and employees themselves. Through constant learning, we will grow into talented people with the best competence in a rapidly changing era.”
Hanmi Pharmaceutical Group also held an online opening ceremony for the first time since its founding due to the spread of Corona 19 on the 4th. On the morning of this morning, employees of group companies such as Hanmi Science, Hanmi Pharmaceutical, Beijing Hanmi Pharmaceutical, Hanmi Fine Chemical, Hanmi Healthcare, Online Farm, JVM, etc. Watched.
In his New Year’s address, Hanmi Pharmaceutical Chairman Song Young-sook declared’Endless Challenge, New Commitment for a Pharmaceutical Powerhouse’ as the management slogan of the Hanmi Pharmaceutical Group in 2021.
Chairman Song said, “Chairman Sundae took’respect for humanity’ and’creating value’ as the management philosophy, and established Hanmi Pharmaceutical Group on this value. “I will never forget this precious value and philosophy,” he said. “I will do my best to build a solid foundation and act as a cornerstone to support Hanmi Pharmaceutical Group to move forward with the goal and vision for a pharmaceutical powerhouse.”
Boryeong Pharmaceutical also held a kick-off ceremony online on this day. As a management policy in 2021, Boryeong Pharmaceutical announced’continue to discover and invest in future growth engines’,’Complete the 10th anniversary Kanab myth’,’Realize the new Boryeong by installing successful DNA’, and’Enhance manufacturing competitiveness’.
Ahn Jae-hyun, CEO of Boryeong Pharmaceutical, said in his New Year’s address, “This year will be a year when the internal and external business environment is not easy. With drastic change and innovation, we must not only achieve this year’s goal, but also create a foundation for the future.” “It will be.”
GC Green Cross started its business this year by notifying management messages online without a separate opening ceremony.
GC Green Cross President Huh Eun-cheol said in his New Year’s address, “I hope that it will be a strong, reliable, and indispensable company for many people in a difficult situation passing through the middle of the pandemic.” We must practice a lot of sharing and volunteer work to help neighbors in need.”
In addition, “Let’s be a strong company based on the action of always diligently preparing to respond to crises that come without notice and not to miss opportunities.” I emphasized.
Chong Kun Dang also announced the start of business in earnest through Chairman Jang-Han Lee’s New Year’s Address. Through his New Year’s address, Chairman Lee shared the performance of each sector in 2020 and management goals for 2021.
In his New Year’s address, Chairman Lee said, “This year marks the 80th anniversary of Chong Kun Dang’s founding. “Let’s lead the leap forward,” he said.
In addition, “Please do our best for this year’s management goal of’discovering growth engines and building smart management’. It should be a year to lead change with a creative and creative mind, and to set the stage for a great leap forward with challenge and innovation. I will.”
Some pharmaceutical companies announced their second start in 2021.
On the 4th, Lee Yeon Pharm unveiled a new corporate identity (CI) with the will to prepare for a second leap forward. In addition, Lee Yeon Pharm has also renewed and opened its corporate website.
An official from Lee Yeon Pharm said, “It reflected the company’s ultimate goal for the next 100 years and the will to further contribute to the life and health of mankind through the second leap forward as a global bio & chemical specialty pharmaceutical company.”
Samjin Pharmaceutical’s New Year’s Address in 2021 showed expectations for the’Era of the Magok Central Research Institute’.
Samjin Pharmaceutical CEO Hong-soon Chang and Yong-ju Choi said, “Last year, we experienced a difficult market environment and internal and external confusion of Corona 19.” “2021 is the time to overcome this and bring about the fruits of growth even in difficult situations. Let’s gather the wisdom to grow up to be.”
In addition, he urged, “In the pharmaceutical and consumer health sectors, we have ordered continuous growth through thorough market analysis, and the R&D department should settle in the Magok Central Research Center, which will be relocated this year, and make efforts to create tangible R&D results.” .
Shinshin Pharm held its first opening ceremony at the Magok R&D Center, which it relocated last year, and started working for the new year.
In his New Year’s Address, Shinshin Pharmaceutical President Lee Byung-ki said, “It is a difficult situation for all because Corona 19 has not been ended, but if the employees become one, as Shinshin Pharmaceutical has been, we will be able to overcome the crisis.” Through this, we will expand the pipeline and speed up the development of specialty drugs in patch formulations that take advantage of Shinshin Pharmaceutical’s unique strengths.”